Dynavax Technologies Corporation news

   Watch this stock
Showing stories 1 - 4 of about 4   

Articles published

DVAX 29.41 +0.19 (0.65%)
price chart
85% Probability Of FDA Approval For Dynavax's Heplisav, Says Cowen's Senior ...
One of them is Dynavax Technologies (NASDAQ:DVAX), a clinical-stage biopharmaceutical company that discovers and develops novel products to prevent and treat infectious and inflammatory diseases.
6 Stocks Trading Under $5 on Winning Streaks
Dynavax Technologies Corporation (DVAX, Earnings, Analysts, Financials): A clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases.
Biodefense Industry - Market to Benefit from Federal Funding such as the BIO ...
7.2.1 Biodefense Contracts 31. 7.3 Bavarian Nordic 32. 7.3.1 Biodefense Contracts 32. 7.4 Cleveland BioLabs 33. 7.4.1 Biodefense Contracts 33.
Apple Inc. (NASDAQ:AAPL) to Double Memory for New Mac minis and iMacs, Retains ...
The company will reportedly enable users buy up to 32GB in new iMac models that could be launched as early as next week. The iMac RAM will be sold in pieces of 8GB chips, something Apple Inc. (AAPL) has not offered previously.